P. Cantor

2.2k citations
44 papers · 1.7k · 1 hit paper · h-index 20

Impact in

Papers in

P. Cantor

44 papers receiving 1.6k citations

Hit Papers

The efficacy and safety of degarelix: a 12‐month, comparative, randomized, open‐label, parallel‐group phase III study in patients with prostate cancer 2008 · 447 citations
4470+6+12Years since publication100200300400

Peers

P. Cantor
Comparison fields: 5 of 84
  • Endocrinology, Diabetes and Metabolism 562
  • Cellular and Molecular Neuroscience 502
  • Endocrine and Autonomic Systems 135
  • Gastroenterology 103
  • Oncology 426
Replace Stig Ingemansson with:
Stig Ingemansson Sweden
Morten Wøjdemann Denmark
Kristine Juul Hare Denmark
A P Savage United Kingdom
C N Mallinson United Kingdom
W. A. Scherbaum Germany
Thomas P. Conlon United States
Fischer Ja Switzerland
Miina K. Öhman United States
J.A. Chayvialle France
P. Cantor relative to Stig Ingemansson Sweden Stig Ingemansson's profile →
Citations per field
00.5×11.3×
Stig Ingemansson · 1×
Citations per year

Countries citing papers authored by P. Cantor

Since Specialization
Citations

This map shows the geographic impact of P. Cantor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Cantor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Cantor more than expected).

Fields of papers citing papers by P. Cantor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Cantor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Cantor. The network helps show where P. Cantor may publish in the future.

Co-authors

The 25 scholars most cited alongside P. Cantor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with P. Cantor Line = papers co-authored together P. Cantor links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The efficacy and safety of degarelix: a 12‐month, comparative, randomized, open‐label, parallel‐group phase III study in patients with prostate cancer
Hit paper breakdown →
2008447
2 2005143
3 1987138
4 198991
5 198689
6 199277
7 199560
8 198949
9 199240
10 198739
11 198633
12 198932
13 198629
14 198627
15 198725
16 198824
17 198823
18 198922
19 199122
20 198920

About P. Cantor

P. Cantor is a scholar working on Cellular and Molecular Neuroscience, Surgery, Endocrinology, Diabetes and Metabolism, Oncology and Epidemiology, having authored 44 papers that have together received 1.7k indexed citations. Recurring topics across this work include Neuropeptides and Animal Physiology (28 papers), Diabetes Treatment and Management (10 papers), Neuroendocrine Tumor Research Advances (9 papers), Peptidase Inhibition and Analysis (8 papers), Pancreatic function and diabetes (5 papers), Pancreatitis Pathology and Treatment (5 papers), Gastrointestinal motility and disorders (5 papers) and Receptor Mechanisms and Signaling (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (562 citations), Cellular and Molecular Neuroscience (502 citations), Endocrine and Autonomic Systems (135 citations), Gastroenterology (103 citations) and Oncology (426 citations). P. Cantor has collaborated with scholars based in Denmark, Sweden and Germany. Frequent co-authors include Tine Kold Olesen, Laurence Klotz, Fritz H. Schröder, Bo‐Eric Persson, Neal D. Shore, L Boccon-Gibod, Jens F. Rehfeld, W. Creutzfeldt, Ole Olsen and Ove B. Schaffalitzky de Muckadell. Their work appears in journals such as Scandinavian Journal of Gastroenterology, Digestion, Pancreas, Gastroenterology and Regulatory Peptides.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact